Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of isosorbide oral solution compared with placebo in people with unilateral Meniere's disease. A total of approximately 234 subjects will be enrolled in this study: 72 subjects in phase and approximately 162 subjects in phase . Patients were randomly assigned to either the experimental group or the control group. The randomization ratios for phase and phase were 1:1 and 2:1, respectively.